Who pays for menopausal hormone therapy (MHT) in Canada, province by province.

Free under PharmaCare (since 2024).

BC PharmaCare covers menopausal hormone therapy, patches, gels, oral estradiol, micronized progesterone, with no out-of-pocket cost for residents. The first province to do this. You still need a prescription; the cost at the pharmacy is what changes. BC Women's Hospital, the Women's Health Research Institute, UBC and the BC Women's Health Foundation are also building Western Canada's first dedicated Menopause + Midlife Health Program: a referral-based provincial clinic for complex midlife care, paired with research and clinician training. It's in fundraising and build-out as of early 2026, not yet open for general referrals, but it's the closest thing in the country to a publicly-anchored specialist menopause centre.

Free under provincial coverage (added 2025).

Manitoba followed BC and added MHT to its provincial drug benefit. Same shape: prescription required, dispensing fees may still apply at some pharmacies, but the medication itself is covered. Manitoba is also the only province (as of early 2026) with menopause-specific GP billing codes, meaning family doctors can be paid for the longer, more complex appointments menopause care actually takes. That's a quiet structural reason it's easier to get a thorough first conversation there than in most of the country.

Covered only via OHIP+ (under 25), ODB (65+), or employer plan.

If you're between 25 and 64 with no private drug coverage in Ontario, which is most women in the menopause window, you pay out of pocket or through your employer's benefits. The Ontario Drug Benefit kicks in at 65 and covers most MHT formulations. Ontario Health (Health Quality Ontario) published a Quality Standard for menopause care in 2024, which sets out what good assessment, MHT counselling, and follow-up should look like across the province. It isn't a funding decision, but it gives you something concrete to point at when you're asking a clinician for a fuller conversation. Several patient-advocacy campaigns are also pushing for universal MHT coverage; nothing has passed as of early 2026.

Covered through RAMQ public drug plan (if you're enrolled).

Quebec's prescription drug regime is unique: every resident must have either employer drug coverage or be enrolled in the RAMQ public plan. Most MHT formulations are on the RAMQ formulary. You'll still owe the standard RAMQ premium and co-pay structure, but it's meaningfully cheaper than fully out-of-pocket.

No general public coverage; private/employer or out of pocket.

Alberta covers MHT for seniors (65+) via the Alberta Seniors Benefit and for some recipients of AISH or income support. For working-age women, it's whatever your employer benefits cover. Generic estradiol and micronized progesterone are typically the cheapest cash-pay options.

No general public coverage; senior and special-support programs only.

Saskatchewan's drug plan covers MHT for seniors and some special-support categories. Most working-age women pay through employer plans or out of pocket. Costs vary widely by formulation, patches and gels tend to be more expensive than generic oral estradiol.

Public plans cover seniors and special groups; otherwise out of pocket.

The Atlantic provinces all run senior-focused drug plans (NS Pharmacare, NB Drug Plan, PEI Pharmacare, NL Pharmaceutical Services). For women in the typical menopause window, MHT is usually paid through employer benefits or directly. Some special low-income programs exist; eligibility varies sharply by province.

Territorial plans and Non-Insured Health Benefits (NIHB) for First Nations and Inuit.

The territories have their own drug benefit plans with broader public coverage than most provinces. NIHB (federal) covers prescription medications including most MHT for registered First Nations and Inuit residents Canada-wide. Coverage of specific formulations varies, confirm with your local health centre or pharmacist.